Hein te Riele

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. ncbi Retinoblastoma teaches a new lesson
    Hein te Riele
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cell 131:227-9. 2007
  2. ncbi Restriction beyond the restriction point: mitogen requirement for G2 passage
    Floris Foijer
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands
    Cell Div 1:8. 2006
  3. ncbi Recreating stem cells: a novel entrance to the fountain of youth
    Hein te Riele
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Cell Stem Cell 4:279-80. 2009
  4. ncbi Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells
    Marieke Aarts
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Nucleic Acids Res 34:e147. 2006
  5. ncbi Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides
    Marleen Dekker
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Mutat Res 715:52-60. 2011
  6. ncbi The APC/C recruits cyclin B1-Cdk1-Cks in prometaphase before D box recognition to control mitotic exit
    Wouter van Zon
    Division of Molecular Biology and 2 Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, Netherlands
    J Cell Biol 190:587-602. 2010
  7. ncbi Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells
    Nanna Claij
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Oncogene 23:260-6. 2004
  8. ncbi Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg
    Henri J van de Vrugt
    Department of Clinical Genetics, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
    DNA Repair (Amst) 10:1252-61. 2011
  9. ncbi Mitogen requirement for cell cycle progression in the absence of pocket protein activity
    Floris Foijer
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Cell 8:455-66. 2005
  10. ncbi Parameters of oligonucleotide-mediated gene modification in mouse ES cells
    Marieke Aarts
    Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Cell Mol Med 14:1657-67. 2010

Collaborators

  • Floris Foijer
  • Rene H Medema
  • Marc Vooijs
  • Jan Hermen Dannenberg
  • Jacob B Hansen
  • Anton Berns
  • Maureen E Hoatlin
  • Jenny A Visser
  • S Cinti
  • Marieke Aarts
  • Marleen Dekker
  • Henri J van de Vrugt
  • Sietske T Bakker
  • Anja van der Wal
  • Anneke B Oostra
  • Hans Joenje
  • Sandra de Vries
  • Nanna Claij
  • Fre Arwert
  • Eva A L Wielders
  • Martin van der Valk
  • Elly Delzenne-Goette
  • Johan P de Winter
  • Tanja van Harn
  • Wouter van Zon
  • Martin A Rooimans
  • Tinke L Vormer
  • Conny Brouwers
  • Annica Gad
  • Piet Kramer
  • Mariska Ad Berns
  • Marieke van de Ven
  • Roberto Tonelli
  • Glenn E Morris
  • Niels de Wind
  • Robert Dekker
  • Yne de Vries
  • Mariska A D Berns
  • Oliver Wiebenga
  • Erika Cantelli
  • Ian Holt
  • Rob J Dekker
  • Mireille Koomen
  • Martin A van der Valk
  • Ngan Ching Cheng
  • Sietske Bakker
  • Anneke Oostra
  • Rob M F Wolthuis
  • Fentang Yang
  • Bas ter Riet
  • Ruby Banerjee
  • Marcel van Vugt
  • Janneke Ogink
  • Jurgen Steltenpool
  • Camiel L C Wielders
  • Staffan Stromblad
  • Minna Thullberg
  • Leon Jansen

Detail Information

Publications25

  1. ncbi Retinoblastoma teaches a new lesson
    Hein te Riele
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cell 131:227-9. 2007
    ..They show that retinoblastoma is not driven by uncontrolled expansion of retinal progenitor cells, but rather is the result of cell cycle re-entry and expansion of differentiated horizontal interneurons in the retina...
  2. ncbi Restriction beyond the restriction point: mitogen requirement for G2 passage
    Floris Foijer
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands
    Cell Div 1:8. 2006
    ..Here, we discuss the similarities and differences between these restriction points and the roles of cyclin-dependent kinase inhibitors (CKIs) herein...
  3. ncbi Recreating stem cells: a novel entrance to the fountain of youth
    Hein te Riele
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Cell Stem Cell 4:279-80. 2009
    ..In this issue of Cell Stem Cell, Liu et al. (2009) demonstrate that a similar transition can be achieved by culturing retinoblastoma-deficient mouse embryonic fibroblasts in suspension...
  4. ncbi Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells
    Marieke Aarts
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Nucleic Acids Res 34:e147. 2006
    ..We have used this method to create a codon substitution (N750F) in the Rb gene of mouse ES cells and show that the oligonucleotide-modified Rb allele can be transmitted through the germ line of mice...
  5. ncbi Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides
    Marleen Dekker
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Mutat Res 715:52-60. 2011
    ..Thus, transient MLH1 suppression provides a valuable extension of the MSH2 knockdown strategy, allowing rapid generation of mice carrying single basepair alterations in their genome...
  6. ncbi The APC/C recruits cyclin B1-Cdk1-Cks in prometaphase before D box recognition to control mitotic exit
    Wouter van Zon
    Division of Molecular Biology and 2 Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, Netherlands
    J Cell Biol 190:587-602. 2010
    ..This suggests that the spindle checkpoint blocks D box recognition of APC/C-bound cyclin B1, whereas distinctive complexes between the N terminus of cyclin A and Cdc20 evade checkpoint control...
  7. ncbi Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells
    Nanna Claij
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Oncogene 23:260-6. 2004
    ..In addition, we were not able to derive cisplatin-resistant subclones from this freshly generated MMR-deficient cell line. Thus, in ES cells we did not find evidence for direct involvement of MMR deficiency in cisplatin resistance...
  8. ncbi Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg
    Henri J van de Vrugt
    Department of Clinical Genetics, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
    DNA Repair (Amst) 10:1252-61. 2011
    ..The lack of an augmented phenotype suggest that null mutations in Fanca or Fancg are fully epistatic, making additional important functions outside of the FA core complex highly unlikely...
  9. ncbi Mitogen requirement for cell cycle progression in the absence of pocket protein activity
    Floris Foijer
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Cell 8:455-66. 2005
    ..The involvement of p53 provides a rationale for the synergism between loss of Rb and p53 in tumorigenesis...
  10. ncbi Parameters of oligonucleotide-mediated gene modification in mouse ES cells
    Marieke Aarts
    Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Cell Mol Med 14:1657-67. 2010
    ..The ability of ES cells to differentiate into various cell types after ssODN-mediated gene targeting may offer opportunities for future therapeutic applications...
  11. ncbi Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling
    Tanja van Harn
    Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Genes Dev 24:1377-88. 2010
    ..This mechanism may allow premalignant tumor cells to acquire additional genetic alterations that promote tumorigenesis...
  12. ncbi Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2
    Tinke L Vormer
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Mol Cell Biol 28:7263-73. 2008
    ..Since transformation of human fibroblasts also requires ablation of both pathways, our results imply that the mechanisms underlying transformation of human and mouse cells are not as different as previously claimed...
  13. ncbi Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M
    Sietske T Bakker
    Division of Molecular Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Hum Mol Genet 18:3484-95. 2009
    ..The FA-M mouse model presented here suggests that FANCM functions both inside and outside the FA core complex to maintain genome stability and to prevent tumorigenesis...
  14. ncbi In vivo significance of the G2 restriction point
    Floris Foijer
    Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Cancer Res 67:9244-7. 2007
    ..These results indicate that the G2 restriction point does operate in vivo. However, in the pituitary gland, this mechanism seems to retard rather than to prevent tumor growth...
  15. ncbi Fancf-deficient mice are prone to develop ovarian tumours
    Sietske T Bakker
    Division of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Pathol 226:28-39. 2012
    ..Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd...
  16. ncbi Check, double check: the G2 barrier to cancer
    Floris Foijer
    Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Cell Cycle 5:831-6. 2006
    ..Thus, progression to malignancy of Rb-deficient lesions by alleviation of G2 arrest may offer an alternative explanation for the synergism between loss of Rb and p53 in tumorigenesis...
  17. ncbi Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130
    Jan Hermen Dannenberg
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Genes Dev 18:2952-62. 2004
    ..The redundancy of the retinoblastoma proteins in vivo is reflected by the behavior of Rb-family-defective mouse embryonic fibroblasts in vitro...
  18. ncbi DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis
    Nanna Claij
    Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
    Cancer Res 63:2062-6. 2003
    ..Mutation analysis of ENU-induced Hprt mutants revealed that base substitutions occurred predominantly at A-T base-pairs. These results suggest that MMR modulates the processing of ethylation damage at AT base-pairs...
  19. ncbi Subtle gene modification in mouse ES cells: evidence for incorporation of unmodified oligonucleotides without induction of DNA damage
    Marieke Aarts
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Nucleic Acids Res 38:6956-67. 2010
    ....
  20. ncbi Targeted gene modification in mismatch-repair-deficient embryonic stem cells by single-stranded DNA oligonucleotides
    Marleen Dekker
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Nucleic Acids Res 31:e27. 2003
    ..We show that PCR-based procedures can be used to identify and clone modified cells. By this method we have substituted a single codon in the retinoblastoma gene...
  21. ncbi Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells
    Marc Vooijs
    Division of Molecular Genetics, The Netherlands Cancer Institute Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Oncogene 21:4635-45. 2002
    ..Our results highlight the important differences that exist in tumor susceptibility between mice and man (e.g pineal gland) and question the photoreceptor cell origin of human retinoblastoma...
  22. ncbi Characterization of MSH2 variants by endogenous gene modification in mouse embryonic stem cells
    Eva A L Wielders
    The Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, The Netherlands
    Hum Mutat 32:389-96. 2011
    ..We have also shown that oligonucleotide-directed gene modification provides a straightforward approach to recreate allelic variants in the endogenous gene in murine ESC. This approach can be extended to other hereditary conditions...
  23. ncbi Novel function of the retinoblastoma protein in fat: regulation of white versus brown adipocyte differentiation
    Jacob B Hansen
    The Netherlands Cancer Institute, Division of Molecular Biology, The Netherlands
    Cell Cycle 3:774-8. 2004
    ..Here we summarize the current knowledge on the retinoblastoma protein in fat cells, with particular emphasis on its potential role in adipocyte lineage commitment and differentiation...
  24. ncbi Retinoblastoma susceptibility gene product (pRb) and p107 functionally separate the requirements for serum and anchorage in the cell cycle G1-phase
    Annica Gad
    Department of Laboratory Medicine, 141 86 Huddinge, Sweden
    J Biol Chem 279:13640-4. 2004
    ....
  25. ncbi Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation
    Jacob B Hansen
    Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark
    Proc Natl Acad Sci U S A 101:4112-7. 2004
    ..We propose that pRB acts as a molecular switch determining white vs. brown adipogenesis, suggesting a previously uncharacterized function of this key cell cycle regulator in adipocyte lineage commitment and differentiation...